BeStock  

Neurocrine Biosciences NBIX

US equityMarket cap rank #693Drug Manufacturers - Specialty & Generic
$142.39 +$0.55 (+0.38%)
Market open · Oct 1, 11:50 am ET · After hours $141.00 -0.59%
Open$140.94
Prev close$141.84
Day range$140.54 – $143.01
Volume429.9K
Market cap$14.47B
P/E (TTM)20.8
Dividend yield–

Analyst view

ConsensusBuy
Analysts24
Average target$209.96+47.5% vs. price
  • Buy 88%
  • Hold 13%
Low $165.00Now $142.39Avg $209.96High $253.00

Recent rating changes

The last 20 actions on file set price targets from $165.00 to $253.00, averaging $204.50.

DateFirmRatingTarget
1 Oct 2026 Piper Sandler BUY $210.00
28 Sep 2026 UBS BUY $214.00
25 Sep 2026 Bernstein BUY $218.00
21 Sep 2026 RBC Capital BUY $187.00
14 Sep 2026 RBC Capital BUY $198.00
11 Sep 2026 Morgan Stanley HOLD $183.00
8 Sep 2026 RBC Capital BUY $198.00
4 Sep 2026 Citi BUY $253.00
3 Sep 2026 Citi BUY $253.00
24 Aug 2026 Morgan Stanley HOLD $182.00
17 Aug 2026 Evercore BUY $215.00
17 Aug 2026 BMO Capital HOLD $190.00
13 Aug 2026 Morgan Stanley HOLD $182.00
13 Aug 2026 Deutsche Bank HOLD $165.00
12 Aug 2026 Bernstein BUY $218.00
12 Aug 2026 BMO Capital HOLD $190.00
6 Aug 2026 J.P. Morgan BUY $217.00
3 Aug 2026 CCORF BUY $210.00
3 Aug 2026 Truist Financial BUY $213.00
3 Aug 2026 Wedbush BUY $194.00

Discussion

No comments yet — be the first to weigh in on NBIX.

Leave a comment

Scroll to Top